Custom Search Insider Trading Activity
Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Custom Search
Updated Jun 06, 2025
| KROS | Keros Therapeutics, Inc. | 15.75K | — | — | Jun 6, 2025 | Grant | — | 1.03M | — | Jun 4 | — | View | |
| CMPX | Compass Therapeutics, Inc. | -3.57M | $1.59 | -$5.68M | Apr 11, 2025 | Sale | -100.00% | 15.22M | — | Apr 9 | — | View | |
| MBX | MBX Biosciences, Inc. | 190.67K | $10.60 | $2.02M | Feb 19, 2025 | Purchase | 5.00% | 4.00M | — | Feb 14 - Feb 18 | — | View | |
| CMPX | Compass Therapeutics, Inc. | 40.00K | — | — | Feb 13, 2025 | Grant | — | 40.00K | — | Feb 11 | — | View | |
| — | Lomond Therapeutics Holdings, Inc. | 1.44M | $3.74 | $10.00M | Nov 5, 2024 | Options | 117.04% | 2.68M | — | Nov 1 | — | View | |
| — | Lomond Therapeutics Holdings, Inc. | — | — | — | Nov 5, 2024 | — | — | — | — | May 11 | — | View | |
| MBX | MBX Biosciences, Inc. | -33.00M | $16.00 | — | Sep 17, 2024 | Buy-Options | -89.64% | 3.81M | — | Sep 16 | — | View | |
| MBX | MBX Biosciences, Inc. | 15.96K | — | — | Sep 13, 2024 | Grant | — | 15.96K | — | Sep 12 | — | View | |
| MBX | MBX Biosciences, Inc. | — | — | — | Sep 12, 2024 | — | — | — | — | May 11 | — | View | |
| ACET | Adicet Bio, Inc. | — | — | — | Aug 23, 2024 | Acq/Dis | — | 93.40K | — | Aug 21 | — | View | |
| KROS | Keros Therapeutics, Inc. | -250.00K | $44.01 | -$11.00M | Aug 15, 2024 | Sale | -19.70% | 1.02M | — | Aug 13 | — | View | |
| TERN | Terns Pharmaceuticals, Inc. | -56.16K | $10.00 | -$561.64K | Jul 17, 2024 | Sale | -0.37% | 15.13M | — | Jul 15 - Jul 16 | Scheduled | View | |
| TERN | Terns Pharmaceuticals, Inc. | 4.68K | — | — | Jul 2, 2024 | Grant | — | 4.68K | — | Jul 1 | — | View | |
| TERN | Terns Pharmaceuticals, Inc. | 32.00K | — | — | Jun 14, 2024 | Grant | — | 32.00K | — | Jun 10 | — | View | |
| ACET | Adicet Bio, Inc. | 32.30K | — | — | Jun 7, 2024 | Grant | 547.46% | 11.49M | — | Jun 5 | — | View | |
| KROS | Keros Therapeutics, Inc. | 10.00K | — | — | Jun 3, 2024 | Grant | — | 10.00K | — | May 30 | — | View | |
| PHGE | BiomX Inc. | -24.34K | $0.31 | $2.26M | May 20, 2024 | Sale | -0.18% | 13.77M | — | May 15 | — | View | |
| KNTE | Kinnate Biopharma Inc. | -8.10M | — | — | Apr 5, 2024 | Disposition | -100.00% | — | — | Apr 3 | — | View | |
| PHGE | BiomX Inc. | 2.17M | — | — | Mar 19, 2024 | Purchase | — | 2.17M | — | Mar 15 | — | View | |
| THRX | Theseus Pharmaceuticals, Inc. | -17.72M | — | — | Feb 14, 2024 | Disposition | -100.00% | — | — | Feb 14 | — | View | |
| CMPX | Compass Therapeutics, Inc. | 40.00K | — | — | Feb 14, 2024 | Grant | — | 40.00K | — | Feb 9 | — | View | |
| — | ArriVent Biopharma, Inc. | 444.44K | $18.00 | $4.00M | Jan 31, 2024 | Purchase | 9.46% | 5.14M | — | Jan 30 | — | View | |
| ACET | Adicet Bio, Inc. | 3.13M | $2.40 | $7.50M | Jan 26, 2024 | Purchase | 47.01% | 11.45M | — | Jan 25 | — | View | |
| — | ArriVent Biopharma, Inc. | — | — | — | Jan 25, 2024 | — | — | — | — | May 11 | — | View | |
| ACET | Adicet Bio, Inc. | — | — | — | Aug 16, 2023 | Acq/Dis | — | 93.40K | — | Aug 14 | — | View | |
| THRX | Theseus Pharmaceuticals, Inc. | 479.93K | $3.05 | $1.46M | Jul 19, 2023 | Purchase | 2.78% | 17.71M | — | Jul 17 | — | View | |
| ACET | Adicet Bio, Inc. | 875.00K | $2.09 | $1.83M | Jun 29, 2023 | Purchase | 12.10% | 8.32M | — | Jun 27 | — | View | |
| TERN | Terns Pharmaceuticals, Inc. | 32.00K | — | — | Jun 14, 2023 | Grant | — | 32.00K | — | Jun 12 | — | View | |
| KNTE | Kinnate Biopharma Inc. | 25.00K | — | — | Jun 13, 2023 | Grant | — | 25.00K | — | Jun 12 | — | View | |
| THRX | Theseus Pharmaceuticals, Inc. | 22.75K | — | — | Jun 13, 2023 | Grant | — | 22.75K | — | Jun 13 | — | View | |
| KROS | Keros Therapeutics, Inc. | 10.00K | — | — | Jun 8, 2023 | Grant | — | 10.00K | — | Jun 6 | — | View | |
| ACET | Adicet Bio, Inc. | 32.30K | — | — | Jun 2, 2023 | Grant | — | 32.30K | — | Jun 1 | — | View | |
| KNTE | Kinnate Biopharma Inc. | 1.46M | $2.78 | $4.09M | May 8, 2023 | Purchase | 21.20% | 8.89M | — | May 4 - May 5 | — | View | |
| KNTE | Kinnate Biopharma Inc. | 1.41M | $2.61 | $3.67M | May 2, 2023 | Purchase | 10.11% | 15.84M | — | Apr 28 - May 2 | — | View | |
| PHGE | BiomX Inc. | 2.14M | $0.25 | $85.26K | Mar 17, 2023 | Purchase | 75.99% | 4.95M | — | Feb 27 | — | View | |
| KNTE | Kinnate Biopharma Inc. | 1.10M | — | — | Feb 22, 2023 | Grant | — | 5.14M | — | Feb 17 | — | View | |
| CMPX | Compass Therapeutics, Inc. | 60.00K | — | — | Feb 9, 2023 | Grant | — | 60.00K | — | Feb 8 | — | View | |
| TERN | Terns Pharmaceuticals, Inc. | 137.93K | $7.25 | $1.00M | Dec 28, 2022 | Purchase | 2.91% | 7.62M | — | Dec 23 | — | View | |
| CMPX | Compass Therapeutics, Inc. | 402.00K | $3.21 | $1.29M | Nov 10, 2022 | Purchase | 2.71% | 18.79M | — | Nov 8 | — | View | |
| THRX | Theseus Pharmaceuticals, Inc. | 192.00K | $5.21 | $1.00M | Nov 9, 2022 | Purchase | 1.16% | 17.23M | — | Nov 7 | — | View | |
| TERN | Terns Pharmaceuticals, Inc. | 4.00M | $2.42 | $8.93M | Aug 18, 2022 | Purchase | 105.51% | 7.79M | — | Aug 16 | — | View | |
| TERN | Terns Pharmaceuticals, Inc. | 32.00K | — | — | Jun 21, 2022 | Grant | — | 32.00K | — | Jun 16 | — | View | |
| KNTE | Kinnate Biopharma Inc. | 20.25K | — | — | Jun 15, 2022 | Grant | — | 20.25K | — | Jun 13 | — | View | |
| THRX | Theseus Pharmaceuticals, Inc. | 30.00K | — | — | Jun 13, 2022 | Grant | — | 30.00K | — | Jun 10 | — | View | |
| ACET | Adicet Bio, Inc. | 18.50K | — | — | Jun 3, 2022 | Grant | — | 18.50K | — | Jun 2 | — | View | |
| KROS | Keros Therapeutics, Inc. | 8.29K | — | — | Jun 3, 2022 | Grant | — | 8.29K | — | Jun 1 | — | View | |
| CMPX | Compass Therapeutics, Inc. | 192.52K | $2.18 | $420.48K | May 13, 2022 | Purchase | 1.32% | 18.39M | — | May 11 - May 13 | — | View | |
| CMPX | Compass Therapeutics, Inc. | 125.36K | $1.57 | $197.25K | May 10, 2022 | Purchase | 0.86% | 18.20M | — | May 6 - May 10 | — | View | |
| CMPX | Compass Therapeutics, Inc. | 30.00K | — | — | Feb 23, 2022 | Grant | — | 30.00K | — | Feb 18 | — | View | |
| KNTE | Kinnate Biopharma Inc. | 195.70K | $10.17 | $1.99M | Feb 15, 2022 | Purchase | 5.91% | 4.04M | — | Feb 11 - Feb 15 | — | View | |
| THRX | Theseus Pharmaceuticals, Inc. | 158.42K | $9.97 | $1.58M | Jan 21, 2022 | Purchase | 0.97% | 17.04M | — | Jan 19 - Jan 21 | — | View | |
| THRX | Theseus Pharmaceuticals, Inc. | 44.72K | $9.90 | $442.75K | Jan 13, 2022 | Purchase | 0.27% | 16.88M | — | Jan 11 - Jan 13 | — | View | |
| ACET | Adicet Bio, Inc. | 214.28K | $14.00 | $3.00M | Dec 14, 2021 | Grant | 765.30% | 7.48M | — | Dec 10 | — | View | |
| CMPX | Compass Therapeutics, Inc. | 5.36M | $3.50 | $18.75M | Nov 8, 2021 | Purchase | 42.13% | 18.07M | — | Nov 4 | — | View | |
| THRX | Theseus Pharmaceuticals, Inc. | 625.00K | $16.00 | — | Oct 14, 2021 | Purchase | 3.85% | 16.84M | — | Oct 12 | — | View | |
| THRX | Theseus Pharmaceuticals, Inc. | 22.68K | — | — | Oct 8, 2021 | Grant | — | 22.68K | — | Oct 6 | — | View | |
| THRX | Theseus Pharmaceuticals, Inc. | — | — | — | Oct 6, 2021 | — | — | — | — | May 11 | — | View | |
| IRON | Gemini Therapeutics, Inc. /DE | 17.25K | — | — | Oct 6, 2021 | Grant | — | 17.25K | — | Oct 4 | — | View | |
| ORIC | Oric Pharmaceuticals, Inc. | 16.63K | — | — | Jun 17, 2021 | Grant | — | 16.63K | — | Jun 16 | — | View | |
| KROS | Keros Therapeutics, Inc. | 8.29K | — | — | Jun 3, 2021 | Grant | — | 8.29K | — | Jun 1 | — | View | |
| ACET | Adicet Bio, Inc. | 18.50K | — | — | May 4, 2021 | Grant | — | 18.50K | — | Apr 30 | — | View | |
| ORIC | Oric Pharmaceuticals, Inc. | -103.42K | $23.48 | -$2.43M | Mar 31, 2021 | Sale | -4.47% | 2.21M | — | Mar 29 - Mar 30 | Scheduled | View | |
| ORIC | Oric Pharmaceuticals, Inc. | -112.30K | $24.53 | -$2.75M | Mar 26, 2021 | Sale | -4.62% | 2.32M | — | Mar 24 - Mar 26 | Scheduled | View | |
| ORIC | Oric Pharmaceuticals, Inc. | -32.94K | $26.21 | -$863.34K | Mar 23, 2021 | Sale | -1.34% | 2.43M | — | Mar 19 - Mar 23 | Scheduled | View | |
| ORIC | Oric Pharmaceuticals, Inc. | -66.20K | $27.95 | -$1.85M | Mar 18, 2021 | Sale | -2.62% | 2.46M | — | Mar 16 - Mar 18 | Scheduled | View | |
| ORIC | Oric Pharmaceuticals, Inc. | -238.28K | $30.54 | -$7.28M | Mar 15, 2021 | Sale | -8.62% | 2.53M | — | Mar 11 - Mar 15 | Scheduled | View | |
| TERN | Terns Pharmaceuticals, Inc. | 25.00K | — | — | Feb 26, 2021 | Grant | — | 25.00K | — | Feb 24 | — | View | |
| ACET | Adicet Bio, Inc. | 524.35K | $13.00 | $6.82M | Feb 18, 2021 | Grant | 10.25% | 7.23M | — | Feb 12 | — | View | |
| IRON | Gemini Therapeutics, Inc. /DE | — | — | — | Feb 10, 2021 | — | — | 5.83M | — | May 11 | — | View | |
| TERN | Terns Pharmaceuticals, Inc. | 475.00K | $17.00 | $8.08M | Feb 9, 2021 | Purchase | 7.16% | 7.11M | — | Feb 9 | — | View | |
| TERN | Terns Pharmaceuticals, Inc. | — | — | — | Feb 4, 2021 | — | — | — | — | May 11 | — | View | |
| — | Prevail Therapeutics Inc. | -13.84M | — | — | Jan 26, 2021 | Disposition | -100.00% | — | — | Jan 22 | — | View | |
| KNTE | Kinnate Biopharma Inc. | 478.00 | — | — | Dec 9, 2020 | Options | 0.01% | 3.85M | — | Dec 7 | — | View | |
| KNTE | Kinnate Biopharma Inc. | 750.00K | $20.00 | $15.00M | Dec 4, 2020 | Purchase | — | 750.00K | — | Dec 2 | — | View | |
| KNTE | Kinnate Biopharma Inc. | 40.50K | — | — | Dec 4, 2020 | Grant | — | 40.50K | — | Dec 2 | — | View | |
| KNTE | Kinnate Biopharma Inc. | — | — | — | Dec 2, 2020 | — | — | — | — | May 11 | — | View | |
| ACET | Adicet Bio, Inc. | 6.05M | — | — | Sep 17, 2020 | Grant | — | 6.74M | — | Sep 15 - Sep 17 | — | View | |
| ACET | Adicet Bio, Inc. | — | — | — | Sep 17, 2020 | — | — | 690.06K | — | May 11 | — | View | |
| CMPX | Compass Therapeutics, Inc. | 1.46M | $5.00 | $7.28M | Jun 23, 2020 | Purchase | 12.92% | 12.71M | — | Jun 19 | — | View | |
| CMPX | Compass Therapeutics, Inc. | — | — | — | Jun 23, 2020 | — | — | 11.26M | — | May 11 | — | View | |
| — | Prevail Therapeutics Inc. | 17.00K | — | — | Jun 19, 2020 | Grant | — | 17.00K | — | Jun 17 | — | View | |
| — | Turning Point Therapeutics, Inc. | 8.50K | — | — | Jun 17, 2020 | Grant | — | 8.50K | — | Jun 15 | — | View | |
| ORIC | Oric Pharmaceuticals, Inc. | 281.25K | $16.00 | — | Apr 28, 2020 | Purchase | 11.32% | 2.77M | — | Apr 28 | — | View | |
| ORIC | Oric Pharmaceuticals, Inc. | 16.63K | — | — | Apr 27, 2020 | Grant | — | 16.63K | — | Apr 23 | — | View | |
| ORIC | Oric Pharmaceuticals, Inc. | — | — | — | Apr 23, 2020 | — | — | — | — | May 11 | — | View | |
| KROS | Keros Therapeutics, Inc. | 375.20K | $16.00 | $6.00M | Apr 13, 2020 | Purchase | 22.90% | 2.01M | — | Apr 13 | — | View | |
| KROS | Keros Therapeutics, Inc. | — | — | — | Apr 7, 2020 | — | — | — | — | May 11 | — | View | |
| SWTX | SpringWorks Therapeutics, Inc. | — | — | — | Sep 12, 2019 | — | — | — | — | May 11 | — | View | |
| — | Prevail Therapeutics Inc. | 882.35K | $17.00 | — | Jun 26, 2019 | Purchase | 6.82% | 13.82M | — | Jun 24 | — | View | |
| — | Prevail Therapeutics Inc. | — | — | — | Jun 19, 2019 | — | — | 2.43M | — | May 11 | — | View | |
| ALEC | Alector, Inc. | 20.00K | — | — | May 14, 2019 | Grant | — | 20.00K | — | May 10 | — | View | |
| — | Turning Point Therapeutics, Inc. | -4.38M | $18.00 | — | Apr 24, 2019 | Buy-Options | -68.18% | 2.04M | — | Apr 22 | — | View | |
| — | Turning Point Therapeutics, Inc. | — | — | — | Apr 16, 2019 | — | — | — | — | May 11 | — | View | |
| ALEC | Alector, Inc. | 411.70K | $19.00 | $3.86M | Feb 11, 2019 | Purchase | 3.25% | 13.09M | — | Feb 11 | — | View | |
| ALEC | Alector, Inc. | — | — | — | Feb 6, 2019 | — | — | — | — | May 11 | — | View | |
| — | ARMO BioSciences, Inc. | -4.14M | $30.02 | -$206.13M | Jun 22, 2018 | Disposition | -100.00% | — | — | Jun 22 | — | View | |
| XFOR | Arsanis, Inc. | 10.00K | — | — | Jun 7, 2018 | Grant | — | 10.00K | — | Jun 5 | — | View | |
| — | ARMO BioSciences, Inc. | 18.00K | — | — | Mar 28, 2018 | Grant | — | 18.00K | — | Mar 26 | — | View | |
| XFOR | Arsanis, Inc. | 25.00K | — | — | Mar 5, 2018 | Grant | — | 25.00K | — | Nov 15 | — | View | |
| — | ARMO BioSciences, Inc. | — | — | — | Jan 30, 2018 | Options | — | 4.12M | — | Jan 30 | — | View |
Showing a maximum of 100 results
Market Resources
Trading Tools & Education
- Benzinga Pro Trading Platform
- Options Trading Strategies and News
- Stock Market Trading Ideas and Analysis
- Technical Analysis Charts and Indicators
- Fundamental Analysis and Valuation
- Day Trading Guides and Strategies
- Live Investor Events
- Pre-market Stock Analysis and News
- Cryptocurrency Market Analysis and News
Ring the Bell
A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.
© 2026 Benzinga | All Rights Reserved